Efficacy and safety of denosumab versus zoledronic acid in delaying skeletal-related events in patients with gastrointestinal cancer, pancreas-biliary system cancer, and other rare cancers
- Resource Type
- Article
- Source
- In
Journal of Bone Oncology March 2017 6:37-40 - Subject
- Language
- ISSN
- 2212-1374